Indirect fluorescent antibody method was applied for a detection of lymphocytic choriomeningitis virus (LCMV) antibody in colonies of laboratory animals in Japan. The results showed that the antibody exist in SPF mice (3/152, 2.2%) and conventional mice (30/539, 5.6%) with the titers ranging from 1:10 to 1:160. The antibody was also detected in 2.2% (2/89) of Syrian hamsters, and 2.9% (2/68) of Apodemus agrarius, 21.4% (3/14) of Japanese harvest mice which have been maintained as laboratory colony for several years. However, the antibody was not demonstrated in Mongolian gerbils, Suncus murinus, guinea pigs and rats, thus far.
Lymphocytic choriomeningitis
virus (LC-MV) is a member of the arenavirus group, and is well-known as one of viral zoonoses associated with three clinical forms, i.e. influenza-like symptomes, meningitis, and meningoencephalomyelitis [1] . The virus was first isolated from a patient with acute aseptic meningitis by Armstrong and Lillie in 1934 [2] .
House mice (Mus musculus) is considered as a natural reservoir of the virus. Laboratory mice are easily infected with LCMV from wild mice and the infection persists in colonies of laboratory mice. Hamsters have also high susceptibility to LCMV and become carrier.
Human infections from these rodents have been reported.
In the United States human infections with LCMV occured by contact with pet hamsters and Syrian hamsters (Mesocricetus auratus) in biomedical laboratory colonies [3, 4] . Recently a case of human infection possibly caused by an exposure to house mice was reported in the United States [5] . The contamination of wild and laboratory rodents has been reported in various countries [7] . However, the situation of LCMV contamination in Japanese laboratories has been unknown.
In this paper, we report that the presence of LCMV antibody in laboratory animals in Japan, indicating the contamination with Arena virus group similar to Europe and North America [5] .
A monitoring the antibody level to LCMV in laboratory and field rodents is a crucial keypoint for preventing the human cases in the same way as the virus of hemorrhagic fever with renal syndrome (HFRS) in Japan. Among several serological methods, currently available for the detection of specific LCMV antibodies, i.e. indirect fluorescent antibody (IFA) test, complement fixation test, fluorescent foci inhibition test, radioimmunoassay, IFA test was employed in the present study because of its safety procedure as well as high specificity and sensitivity [8, 9] . were observed mainly in the cytoplasm of the virus-infected L cells. The specificity of the IFA test was examined by using the antisera against Sendai virus, reovirus type 1 to 3, HFRS (76-118) virus. As a positive control, two convalescent human sera of LCMV infected humans which were obtained from Dr. Lehmann-Grube, Heinrich-Pette Institute for Experimental Virology and Immunology, Hamburg University, West Germany, was employed. None of these antisera showed specific fluorescence except anti-LCMV human sera which detected intracytoplasmic virus antigen at dilutions of 1 : 160, and 1 : 320. The specificity of IFA test was further confirmed by the use of plaque-purified LCMV and a blocking test, although the virus-infected hamster serum was not completely blocked against positive animal serum, because of the nature of anti-LCMV antibody reported as low affinity and avidity [10] . The presence of the antibody in SPF mice points out the importance of microbiological monitoring for LCMV. Furthermore, special attention has to be paid for possible human infection with LCMV similar to that in the Western countries [7] .
